Search

Your search keyword '"Mohan, Lauren"' showing total 21 results
Start Over Author "Mohan, Lauren" Publication Year Range Last 10 years
21 results on '"Mohan, Lauren"'

8. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas

Author

Shi, Katherine, primary, Zhang, Bin, additional, Kong, Betty Y., additional, Zhang, Yongzhan, additional, Igartua, Catherine, additional, Mohan, Lauren S., additional, Quan, Victor L., additional, Panah, Elnaz, additional, Isales, Maria Cristina, additional, Beaubier, Nike, additional, Taxter, Timothy J., additional, White, Kevin P., additional, Zou, Lihua, additional, and Gerami, Pedram, additional

Published
2023
Full Text
View/download PDF

10. 15572 Risk factors for Spitz neoplasms

Author

Khan, Ayesha U., primary, Kim, Daniel, additional, Compres, Elsy V., additional, Shi, Katherine, additional, Mohan, Lauren S., additional, Wagner, Annette, additional, Kruse, Lacey, additional, Zhang, Bin, additional, and Gerami, Pedram, additional

Published
2020
Full Text
View/download PDF

11. 18632 Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms

Author

Compres, Elsy V., primary, Shi, Katherine, additional, Walton, Kara E., additional, Mohan, Lauren S., additional, Zhang, Bin, additional, Khan, Ayesha U., additional, Kim, Daniel, additional, Panah, Elnaz, additional, Yazdan, Pedram, additional, Robinson, June, additional, and Gerami, Pedram, additional

Published
2020
Full Text
View/download PDF

14. Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms

Author

Shi, Katherine, primary, Compres, Elsy, additional, Walton, Kara E., additional, Mohan, Lauren S., additional, Zhang, Bin, additional, Panah, Elnaz, additional, Quan, Victor L., additional, Garfield, Erin M., additional, Khan, Ayesha U., additional, Kim, Daniel, additional, Yazdan, Pedram, additional, Robinson, June K., additional, and Gerami, Pedram, additional

Published
2020
Full Text
View/download PDF

17. Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma

Author

Isales, Maria C., primary, Mohan, Lauren S., additional, Quan, Victor L., additional, Garfield, Erin M., additional, Zhang, Bin, additional, Shi, Katherine, additional, Arva, Nicoleta, additional, Beaubier, Nike, additional, Yazdan, Pedram, additional, White, Kevin, additional, Taxter, Timothy J., additional, and Gerami, Pedram, additional

Published
2019
Full Text
View/download PDF

18. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study

Author

Walton, Kara E., primary, Garfield, Erin M., additional, Zhang, Bin, additional, Quan, Victor L., additional, Shi, Katherine, additional, Mohan, Lauren S., additional, Haugh, Alexandra M., additional, VandenBoom, Timothy, additional, Yazdan, Pedram, additional, Isales, Maria Cristina, additional, Panah, Elnaz, additional, and Gerami, Pedram, additional

Published
2019
Full Text
View/download PDF

20. The future of nanomedicine in optimising the treatment of inflammatory bowel disease.

Author

Daly, Jacqueline S., Mohan, Lauren J., Ramtoola, Zebunnissa, and Ryan, Barbara M.

Subjects
*INFLAMMATORY bowel disease treatment, *TARGETED drug delivery
Abstract

There have been major advancements in the treatment of inflammatory bowel disease (IBD) over the past three decades. However despite significant progress, the best available treatments continue to demonstrate variable efficacy in patients and are associated with adverse effects. Therefore there remains an unmet clinical need for ongoing therapeutic advances for IBD. In recent years nanomedicines have emerged as promising diagnostic and therapeutic tools. Nanoparticles in particular show promise to facilitate targeted oral drug delivery in IBD. Here we discuss the pitfalls of current therapies and explore the potential for nanoparticles to improve the treatment of IBD. This review examines the range of conventional and novel therapies which have benefited from nanoparticle-mediated delivery and highlights the proven therapeutic efficacy of this approach in preclinical models. These strategies under development represent a novel and innovative treatment for IBD. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

21. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.

Author

Walton, Kara E, Garfield, Erin M, Zhang, Bin, Quan, Victor L, Shi, Katherine, Mohan, Lauren S, Haugh, Alexandra M, VandenBoom, Timothy, Yazdan, Pedram, Isales, Maria Cristina, Panah, Elnaz, and Gerami, Pedram

Abstract

Background: Repigmentation at previous biopsy sites pose a significant diagnostic dilemma given clinical and histologic similarities between recurrent nevi and locally recurrent melanoma. Though common in melanoma, the role of TERT promoter mutations (TPMs) in recurrent nevi is unknown.Objective: We investigated the role of TPMs in recurrent nevi and whether the presence of hotspot TPM distinguishes recurrent nevi from locally recurrent melanoma. We also characterized clinical and histologic features differentiating these lesions.Methods: We analyzed 11 locally recurrent melanomas, 17 recurrent nevi, and melanoma and nevus controls to determine TPM status. We also assessed clinical and histologic features of the recurrent groups.Results: Hotspot TPMs were more common in recurrent melanomas than recurrent nevi (P = .008). Recurrent melanomas were more likely to have solar elastosis (P = .0047), multilayering of melanocytes in the epidermis (P = .0221), adnexal involvement (P = .0069), and epidermal consumption (P = .0204). Recurrent nevi had intra-epidermal atypia limited to the area above the scar (P < .0001) and occurred earlier after the original biopsy (P < .0008). Solar elastosis, months to recurrence, and hotspot TPMs were independently associated with recurrent melanoma in multivariate analysis.Limitations: This was a retrospective study.Conclusion: Hotspot TPMs are significantly more frequent in recurrent melanomas and could serve as a diagnostic clue in histologically ambiguous cases. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results